Application
A. Western blot analysis on (A) HT29, (B) colon cancer and (C) human small intestine lysates using anti-CDX-2 RabMAb (Cat. #AJ1181a), dilution (A) 1:1000 and (B, C) 1:5000.
Application
B. Immunohistochemical analysis of paraffin-embedded human gastric adenocarcinoma using anti-CDX-2 RabMAb (Cat. #AJ1181a).